Patents by Inventor Gurunadham MUNAGALA

Gurunadham MUNAGALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS TO TARGET HIV-1 NEF-CD80/CD86 INTERACTIONS FOR THERAPEUTIC INTERVENTION
    Publication number: 20220062281
    Abstract: The compounds of Formula I, II, and III along with their stereoisomers, pharmaceutically acceptable salts, polymorphs, solvates and hydrates thereof are described in the present disclosure. The said compounds restore immune activation in case of infections or a disease associated with an HIV infection in a subject in need thereof.
    Type: Application
    Filed: August 13, 2019
    Publication date: March 3, 2022
    Inventors: Satyajit MAYOR, Akankshi MUNJAL, Taslimarlf SAIYED, Anandl KARUMBATl, Ram Aysre VISHWAKARMA, Parvinder Pal SINGH, Shweta SHARMA, Gurunadham MUNAGALA, Kushalava Reddy YEMPALLA, Srinivas AMBALA, Shahid JAMEEL, Satyajit RATH
  • 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof
    Patent number: 9845330
    Abstract: The present invention relates to newer generation of triazoles, tetrazoles, isoxazoles, urea and sulphonamide functionalities containing 6-nitro-2,3-dihydronitroimidazooxazoles agents of formula 1, their method of preparation, and their use as drugs for treating Mycobacterium tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents. In the present invention, new generation 6-nitro-2,3-dihydronitroimidazooxazoles agents also show acceptable pharmacokinetic properties and synergistic or additive effects with known anti-tubercular drugs.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: December 19, 2017
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Parvinder Pal Singh, Gurunadham Munagala, Reddy Yempalla Kushalava, Inshad Ali Khan, Nitin Pal Kalia, Vikrant Singh Rajput, Amit Nargotra, Sanghapal Damodhar Sawant, Ram Asray Vishwakarma
  • Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
    Patent number: 9822126
    Abstract: The present invention relates to new generation of triazole functionality containing 6-nitro-2,3-dihydroimidazooxazole agents for general formula I, their method of preparation and their use as drugs for treatment of tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: November 21, 2017
    Assignee: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Kushalava Reddy Yempalla, Gurunadham Munagala, Samsher Singh, Sumit Sharma, Inshad Ali Khan, Ram Asrey Vishwakarma, Parvinder Pal Singh
  • SUBSTITUTED 1,2,3-TRIAZOL-1-YL-METHYL-2,3-DIHYDRO-2-METHYL-6-NITROIMIDAZO[2,1-B]OXAZOLES AS ANTI-MYCOBACTERIAL AGENTS AND A PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20170313721
    Abstract: The present invention relates to new generation of triazole functionality containing 6-nitro-2,3-dihydroimidazooxazole agents for general formula I, their method of preparation and their use as drugs for treatment of tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents.
    Type: Application
    Filed: September 9, 2015
    Publication date: November 2, 2017
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Kushalava Reddy YEMPALLA, Gurunadham MUNAGALA, Samsher SINGH, Sumit SHARMA, Inshad Ali KHAN, Ram Asrey VISHWAKARMA, Parvinder Pal SINGH
  • 6-NITRO-2,3-DIHYDROIMIDAZO[2,1-b]OXAZOLES AND A PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20160244462
    Abstract: The present invention relates to newer generation of triazoles, tetrazoles, isoxazoles, urea and sulphonamide functionalities containing 6-nitro-2, 3-dihydronitroimidazooxazoles agents of formula 1, their method of preparation, and their use as drugs for treating Mycobacterium tuberculosis, MDR-TB and XDR-TB either alone or in combination with other anti-tubercular agents. In the present invention, new generation 6-nitro-2, 3-dihydronitroimidazooxazoles agents also show acceptable pharmacokinetic properties and synergistic or additive effects with known anti-tubercular drugs.
    Type: Application
    Filed: March 31, 2014
    Publication date: August 25, 2016
    Applicant: Council of Scientific & Industrial Research
    Inventors: Parvinder Pal SINGH, Gurunadham MUNAGALA, Reddy Yempalla KUSHALAVA, Inshad Ali KHAN, Nitin Pal KALIA, Vikrant Singh RAJPUT, Amit NARGOTRA, Sanghapal Damodhar SAWANT, Ram Asray VISHWAKARMA